|
Med Spa Vacations Inc (MDVP) |
|
|
|
|
|
EARNINGS REPORT by CSIMarket
Sales and Earnings Unchanged
Med Spa Vacations Inc announced fiscal time frame ending Sep 30 2020 operating loss of $0 millions
![Picking-Station_Goods-to-Operator_By_TGWmechanics_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/transport/Picking-Station_Goods-to-Operator_By_TGWmechanics_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Picking-Station_Goods-to-Operator_By_TGWmechanics_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons") For the fiscal time frame ending Sep 30 2020 Med Spa Vacations Inc reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter. Sales remained unchanged to $ 0 millions from $0 millions in the same quarter a year ago and sequentially from $0 millions. In the fiscal time frame ending Sep 30 2020 Med Spa Vacations Inc reported net loss of $0.000 million, instead of deficit of $ -0.019 millions in the same quarter a year ago.
|
Recently Reported Results |
Antares Pharma Inc
A $46.28 million tax benefit, helped Antares Pharma Inc to post $0.29 eps in the financial fourth quarter of 2020
Antares Pharma Inc reported earnings of $56.20 millions and Sales of $149.60 millions for the fiscal year 2020.
Company reported earnings per share of $0.33 compared to $-0.01 in the previous fiscal year, while Sales improved by 20.78 % from $123.86 millions a year ago.
ATRS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/construction/Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Construction Spending
U.S. Department of Commerce reported 2.1 % increase in construction spending in January, led by increase in residential construction.
|
![PNC_bank_ATMs_By_myself_ (UserPiotrus)_(Own_work)[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/banks/PNC_bank_ATMs_By_myself_ (UserPiotrus)_(Own_work)[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "PNC_bank_ATMs_By_myself_ (UserPiotrus)_(Own_work)[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Southern First Bancshares Inc
In the fourth quarter of 2020 earnings season outstanding revenue growth surpassed strong eps growth, where Revenues jumped by 27.69% to $25.65 millions, income increased by 19.15 % at $1.10 per share, from the same quarter a year ago.
Eps more than doubled from the preceding quarter by 292.02 % from $0.28 per share, Revenues surged by 49.8 % from $17.12 millions.
In the fiscal year 2020, Southern First Bancshares Inc reported Revenues of $77.56 millions and net income of $18.33 millions.
Earnings deteriorated by -34.64 % to $2.34 per share from $3.58 in the previous fiscal year, while Revenue decreased by -2.99 % from $79.95 millions a year ago.
SFST stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Agilent Technologies inc
For the financial first quarter of 2020 profits soared by 47.62 % to $0.93 per share, followed by Sales increase of 14.08% to $1.55 billions, compared with the prior year period.
From the preceding quarter, earnings grew by 30.28 % from $0.71 per share and Sales increased by 4.38 % from $1.48 billions.
A stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Huttig Building Products Inc
Huttig Building Products Inc announced earnings per share of $0.01 and Sales of $212.70 millions in the fourth quarter of 2020 earnings season, Company's earnings turn positive per share, versus $-0.37 eps, earned in the same quarter a year ago, although Huttig Building Products Inc saw its Sales rise by 2.33% in the same period.
In comparison to previous quarter eps dropped by -95.21% from $0.24 per share and Sales deteriorated by -13.21% from $212.70 millions.
Huttig Building Products Inc reported net loss of $-0.90 millions and Sales of $792.30 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.03 from $-0.84 in the previous fiscal year, while Sales decreased by -2.43 % from $812.00 millions a year ago.
HBP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons](../news/img/food/Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons.JPG "Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons")
Consumer Price Index
|
Employment Report
|
Producer Price Index
|
![ShellMartinez-refi_User.Leonard_G_ _[CC-BY-SA-1.0_(http_creativecommons.org_licenses_by-sa_1.0)]_via_Wikimedia_Common](../news/img/chemical/ShellMartinez-refi_User.Leonard_G_ _[CC-BY-SA-1.0_(http_creativecommons.org_licenses_by-sa_1.0)]_via_Wikimedia_Common.jpg "ShellMartinez-refi_User.Leonard_G_ _[CC-BY-SA-1.0_(http_creativecommons.org_licenses_by-sa_1.0)]_via_Wikimedia_Common")
Luxfer Holdings Plc
In the most recent fiscal period Luxfer Holdings Plc earnings turn positive of $0.25 per share compared to $-0.08 a year ago and eps more than doubled by 181.66 % from $0.09 per share from the previous quarter.
Sales fell sharply by -58.69% to $41.10 millions from $99.50 millions in the same quarter a year ago and sequentially Sales Tumbled by -54.54% from $90.40 millions.
In the fiscal year 2020, Luxfer Holdings Plc reported Sales of $324.80 millions and net income of $20.00 millions.
Eps surged by 554.55 % to $0.72 per share from $0.11 in the previous fiscal year, while Sales fell by -26.76 % from $443.50 millions a year ago.
LXFR stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Boeing_747-400_over_By_Sergey_Kustov__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common](../news/img/airline/Boeing_747-400_over_By_Sergey_Kustov__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common.jpg "Boeing_747-400_over_By_Sergey_Kustov__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common")
Jetblue Airways Corp
Jetblue Airways Corp reported disastrous fourth quarter of 2020, where Sales faded by -67.42% to $662.00 millions and loss per share has widen to $-1.29, from the same quarter a year ago.
Eps more than doubled from the preceding quarter from $-1.44 per share, Sales surged by 34.55 % from $492.00 millions.
Jetblue Airways Corp reported net loss of $-1,354.00 millions and Sales of $2.96 billions for the fiscal year 2020.
Company recorded loss per share of $-4.88 compared to $1.91 in the previous fiscal year, while Sales Tumbled by -63.47 % from $8.09 billions a year ago.
JBLU stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Neuronetics Inc
In the fiscal fourth quarter of 2020 Neuronetics Inc lost money of $-0.19 per share compared to $-0.41 a year ago and increased losses from $-0.18 per share from the previous quarter.
Sales declined in double digits by -10.24% to $15.58 millions from $17.36 millions in the same quarter a year ago and sequentially Sales improved by 25.15 % from $12.45 millions.
Neuronetics Inc reported net loss of $-27.45 millions and Sales of $49.24 millions for the fiscal year 2020.
Company has decreased loss per share to $-1.46 from $-1.58 in the previous fiscal year, while Sales fell by -21.41 % from $62.66 millions a year ago.
STIM stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Glycomimetics Inc
In the fiscal time frame ending Dec 31 2020 Glycomimetics Inc turn a round of $0.45 per share compared to $-0.34 a year ago and EPS turn positive from $-0.29 per share from the previous quarter.
Sales remained unchanged to $0.16 millions from $0.00 millions in the same quarter a year ago and sequentially Sales improved by -83.71% from $1.00 millions.
Glycomimetics Inc reported net loss of $0.00 millions and Sales of $10.16 millions for the fiscal year 2020.
Company has decreased loss per share to $-1.12 from $-1.34 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
GLYC stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Sandwiches_Vienna_By_Jebulon_(Own_work)_[CC0],_via_Wikimedia_Commons](../news/img/food/Sandwiches_Vienna_By_Jebulon_(Own_work)_[CC0],_via_Wikimedia_Commons.jpg "Sandwiches_Vienna_By_Jebulon_(Own_work)_[CC0],_via_Wikimedia_Commons")
B and g Foods inc
Sales for the financial fourth quarter of 2020 increased by 8.52% to $510.24 millions in comparison to $470.17 millions on a year-over-year basis, company posted earnings growth of 17.02 % to $0.19, as comparison at $0.16 in the prior year quarter.
In contrast to the third quarter Sales increased by 2.92 % from $495.76 millions and eps dropped by -73.96% from $0.72 per share.
In the fiscal year 2020, B And G Foods Inc reported Sales of $1.97 billions and net income of $131.99 millions.
Eps soared by 74.36 % to $2.04 per share from $1.17 in the previous fiscal year, while Sales improved by 18.52 % from $1.66 billions a year ago.
BGS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
![Prosciutto_con_melone_By_Nikodem_Nijaki_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons](../news/img/food/Prosciutto_con_melone_By_Nikodem_Nijaki_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons.jpg "Prosciutto_con_melone_By_Nikodem_Nijaki_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons")
Cellectar Biosciences Inc
In the fourth quarter of 2020 earnings season Cellectar Biosciences Inc decreased loss of $-0.12 per share compared to $-0.35 a year ago and improved from $-0.15 per share from the previous quarter.
Cellectar Biosciences Inc reported operating deficit of $-3.799523 millions, in the fourth quarter of 2020 earnings season, a deterioration from the operating loss of $-3.384574 millions, realized in fourth quarter of 2019
Cellectar Biosciences Inc reported net loss of $-15.09 millions and Sales of $0.00 millions for the fiscal year 2020.
Company has decreased loss per share to $-0.76 from $-1.84 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
CLRB stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|
